| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |